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Acute lymphoblastic leukemia (ALL) cells disrupt the healthy bone
marrow microenvironment to create a leukemic niche that is
crucial for facilitating leukemogenesis and protects leukemic cells
from chemotherapeutic agents and immune cells.1,2 However, the
functional mechanisms that regulate this malignant process are
largely unknown. Recently, we showed that tunneling nanotubes
(TNTs) play an important role in the communication between
leukemic cells and bone marrow-derived mesenchymal stromal
cells (MSCs).3,4 TNTs are thin membrane protrusions that are
driven by the actin cytoskeleton.5 We recently showed that ALL
cells use TNTs to signal toward MSCs and subsequently induce
the secretion of pro-survival cytokines, leukemic cell survival and
drug resistance.4 B-cell precursor ALL (BCP-ALL) cells and MSCs
exchange lipophilic molecules using TNTs.4 However, the identity
of the transported cargo needs further elucidation. In this
study, we describe that autophagosomes, mitochondria and the
transmembrane protein ICAM1 are transferred from BCP-ALL cells
toward MSCs in a TNT-dependent manner.
To identify which structures are transferred from leukemic cells
to MSCs via TNTs, we ectopically (that is, non-endogenously)
expressed ﬂuorescently tagged proteins that mark speciﬁc
cellular structures in BCP-ALL cells (NALM6) using lentiviral
vectors (Figure 1a; Supplementary Figure 1). After lentiviral
transduction, we obtained stable BCP-ALL cell clones expressing
turbo RFP (tRFP)-tagged marker proteins. The tRFP-positive BCP-
ALL cells were stained with a nucleus speciﬁc dye (NucBlue), after
which speciﬁc subcellular localization of ﬂuorescent marker
proteins was conﬁrmed by confocal microscopy (Figure 1b). For
example, CALR, which marks the endoplasmatic reticulum, was
expressed at the nuclear border (Figure 1b second panel from
the top).
Next, we co-cultured tRFP-marker protein expressing BCP-ALL
cells with tRFP-negative MSCs (Figure 1c) and quantiﬁed the
transfer of tRFP by ﬂow cytometry (Figure 1d). The B-cell marker
CD19 was used to distinguish between BCP-ALL cells and MSCs
(Figure 1d, second panel). Actin, endoplasmatic reticulum, cyto-
plasm, ICAM1, autophagosomes, mitochondria and early/late/
recycle endosomes were transferred from BCP-ALL cells to MSCs,
since MSCs became increasingly positive for tRFP signal after co-
culture with tRFP-tagged leukemic clones for 24, 48 and 72 h
(Figure 2a). To exclude that tRFP transfer was non-speciﬁc, we
plotted the intensity of tRFP in BCP-ALL cells, that differed 6.9-fold
between the brightest and dimmest clone (cytoplasm versus
endoplasmatic reticulum; Supplementary Figure 2), against the
intensity of tRFP in MSCs after co-culture for 48 h (Figure 2b). No
correlation was found between the amount of transfer and the
intensity of the tRFP signal in the leukemic clone from which the
tRFP-tagged molecule originated (Figure 2b; P=0.48, Pearson
correlation test), showing that the observed transfer is not
explained by non-speciﬁc leakage of tRFP label. This implies that
tRFP transfer from BCP-ALL cells toward MSCs is representative for
transfer of tagged cellular structures. Autophagosomes appeared to
be the most highly transported structure from BCP-ALL cells to
MSCs (three-fold more than other proteins after 48 h; Figure 2c). To
assess the contribution of TNTs to the transfer of cellular structures,
we performed ALL-MSC co-cultures in the absence or presence of
TNT inhibiting conditions for 48 h. TNTs were inhibited by two
established approaches in literature: mechanical disruption of TNTs
through gentle shaking of cell cultures and physical separation of
BCP-ALL cells, and MSCs using a transwell system (3.0 μm pore
size).4,6 While actin inhibitors are often used to inhibit TNTs, their
short half-time and high cytotoxicity prevented their use in these
experiments.4 Transfer of actin (ACTB), endoplasmatic reticulum
(CALR), cytoplasmic content (empty vector) and endosome markers
(RAB family) were inhibited by transwell conditions, but not by
gentle shaking (Figure 2d). This implicates that transfer of these
proteins is driven by cell–cell signaling modules other than TNTs.
For example by gap junctional protein Cx43, which has been shown
to be involved in transfer of extracellular vesicles.7 Interestingly,
transfer of transmembrane protein ICAM1, autophagosomes (LC3B)
and mitochondria (PDHA1) was signiﬁcantly inhibited by both TNT
inhibiting conditions (shaking and transwell; Po0.05, Figure 2d).
Transmembrane proteins and mitochondria have previously been
observed to be transferred via TNTs by other cell types.8,9 Our data
show that this is also true for TNT signaling between BCP-ALL cells
and MSCs. Strikingly, transfer of autophagosomes was three-fold
higher than ICAM1 and PDHA1 transfer (Figure 2c). To our
knowledge, this is the ﬁrst time that autophagosome transfer is
observed between ALL cells and MSC in a TNT-dependent manner.
Autophagy is a process that degrades and recycles unwanted or
damaged cellular components such as proteins and organelles.10 This
process has been implicated as an important regulator of both tumor
initiation and tumor suppression.11 Autophagy is driven by double-
membraned vesicles known as autophagosomes, which are shaped
through the actin cytoskeleton.12 TNT formation is also dependent on
actin4,5 and this co-dependence might be important for autophago-
some transport through the TNTmachinery. Interestingly, autophagy
induction through starvation of cells has been shown to increase the
formation of TNTs,13 suggesting a correlation between these
processes. Recently, we observed that TNT signaling induces the
secretion of pro-survival cytokines.4 Autophagy is a known regulator
of cytokine signaling and this process is inﬂuenced by mitochondrial
reactive oxygen species and/or mitochondrial DNA.14 The transfer
of mitochondria and autophagosomes from leukemic cells toward
MSCs might therefore explain the release of supportive factors by
the tumor microenvironment, as we recently reported elsewhere
(Figure 2e).4 Interestingly, the transcription of ICAM1, a transmem-
brane protein involved in cell–cell adhesion, is known to be
upregulated in response to cytokine signaling and reactive oxygen
species.15 Its transport toward MSCs may provide anchorage to
facilitate TNT function.
In conclusion, these data show the potential of using
ﬂuorescently labeled marker proteins to characterize which
cellular structures are transported by TNT signaling from ALL cells
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Figure 1. Identifying TNT cargo using ﬂuorescently tagged proteins. (a) Schematic overview of ectopically expressed marker proteins that
were used to visualize speciﬁc cellular structures in BCP-ALL cells (NALM6). (b) Representative confocal images showing the subcellular
localization of tRFP-positive marker proteins relative to the nucleus in live NALM6 cells. A transmission image is provided to show the shape
of the leukemic cell (left panel). (c) Experimental setup for visualizing protein transfer from BCP-ALL cells toward MSCs. Leukemic clones
that express tRFP-positive marker proteins were co-cultured with tRFP-negative MSCs and transfer of protein toward was quantiﬁed by
ﬂow cytometry. (d) Gating strategy that was used to quantify transfer of tRFP-positive marker protein from leukemic cells toward MSCs by ﬂow
cytometry. BCP-ALL cells and MSCs are gated based on their forward and sideward scatter (ﬁrst panel), and separated based on CD19
expression (second panel). Finally, the median tRFP signal in MSCs was quantiﬁed with the phycoerythrin channel and used as a measure of
tRFP-positive marker protein transfer (last panel). See also Supplementary Figure 1.
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to MSCs. Our study conﬁrmed several known TNT cargo (that is,
mitochondria and transmembrane proteins)8,9 and revealed
novel structures (autophagosomes) that are transported through
TNTs. The TNT-dependent transfer of autophagosomes and
mitochondria from ALL cells toward MSCs might unveil an
important mechanism that leukemic cells use to affect their
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Figure 2. Autophagosomes, mitochondria and ICAM1 are transferred via tunneling nanotubes. (a) BCP-ALL cells expressing tRFP-markers were
co-cultured with tRFP-negative MSCs for 24 (black bars), 48 (dark-gray bars) and 72 h (light-gray bars). Median intensity of MSCs for tRFP is
shown. (b) Graph showing the median tRFP intensity of MSCs (x axis) compared to BCP-ALL tRFP intensity (y axis) after co-culture for 48 h as
depicted in a. No correlation was found indicating that transfer of tRFP was protein speciﬁc (n= 3, P= 0.48, Pearson correlation test). (c) Graph
showing the transfer of tRFP from BCP-ALL cells toward MSCs after 48 h of co-culture (n= 3). (d) Graph showing the transfer of tRFP from BCP-
ALL cells toward MSCs after TNT inhibition (gray and black bars), compared to normal co-culture conditions (white bars; n= 3; one-tailed t-test,
paired). (e) Model of TNT signaling in the leukemic niche: 1: Leukemic cells use TNT signaling to transfer autophagosomes, mitochondria and
ICAM1 toward MSCs in their microenvironment. 2: Increased reactive oxygen species (ROS) and autophagy in MSCs induces the production of
cytokines. 3: Supportive and nurturing factors are released into the tumor microenvironment, which induce survival and drug resistance in
leukemic cells. Data are means± s.e.m.; *P⩽ 0.05, **P⩽ 0.01. See also Supplementary Figure 2. PE, phycoerythrin.
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microenvironment. Our study suggests that instead of upregulating
autophagy in an indirect manner, leukemic cells transfer autophago-
somes to MSCs in order to enhance autophagy-induced cytokine
secretion. Inaddition,our study identiﬁesautophagosomes, ICAM1and
mitochondriaas important structures thatareactively transported from
leukemic cells toward their microenvironment via TNTs.
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Donor type, in addition to transplantation in chronic phase
and myeloablative conditioning, inﬂuence transplant survival
for patients with advanced chronic myeloid leukemia in the era
of tyrosine kinase inhibitors
Leukemia (2017) 31, 1654–1657; doi:10.1038/leu.2017.118
To the editor:
Treatment of patients with chronic myeloid leukemia
(CML) has changed dramatically over the years with the
introduction of tyrosine kinase inhibitors (TKIs), now considered
standard upfront therapy for this disease. Despite promising
results, outcome of patients who present in advanced-phase or
who progress while on TKI therapy is poor.1,2 Allogeneic
hematopoietic stem cell transplantation (AHSCT) remains the only
potentially curative option for patients with advanced CML.3
Here we conducted a retrospective single-center study
to assess the clinical beneﬁt of AHSCT in patients with
advanced-phase CML in the recent era of TKIs. We also evalu-
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